Aesha Shah

Aesha Shah is an experienced professional in regulatory affairs, currently serving as Associate Director at FibroGen, Inc. since May 2023. Previously, Aesha held multiple positions at BioMarin Pharmaceutical Inc. from March 2015, including Manager and Sr. Manager in CMC Regulatory Affairs, where responsibilities involved managing cross-functional coordination for regulatory submissions, supporting market authorization transfers, and liaising with global teams. Aesha's earlier roles included Research Associate positions at UPMC and Lupin, focusing on In Vitro Screening of new chemical entities for therapeutic applications against cancer and psoriasis. Aesha earned a Master’s degree in Regulatory Affairs from Northeastern University between 2014 and 2017.